{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T16:36:22Z","timestamp":1781800582375,"version":"3.54.5"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T00:00:00Z","timestamp":1613520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold>The coronavirus disease 2019 (COVID-19) pandemic has caused overwhelming challenges in healthcare worldwide. During such an outbreak, some needs of high-risk groups who require regular follow-ups and long-term management are not met. The vulnerable populations include patients with Duchenne muscular dystrophy (DMD). Duchenne muscular dystrophy is characterized by respiratory complications caused by muscle weakness. Hence, patients with this condition are at high risk of severe diseases including COVID-19.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold>To standardize care and provide optimal treatment to DMD patients in Saudi Arabia during the COVID-19 pandemic, a panel of experts including neurologists and pediatricians consolidated recommendations for healthcare professionals and caregivers.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold>During this pandemic, substituting unnecessary clinic visits with virtual clinic services was highly recommended, if possible, without compromising clinical outcomes. Duchenne muscular dystrophy patients with respiratory complications should be closely monitored, and those with cardiovascular complications must continue taking angiotensin-converting enzyme inhibitors or angiotensin receptor blockers. Moreover, individualized home-based rehabilitation management was preferred. Glucocorticoid and new gene correction therapies should be continued. However, new gene correction therapy must be post-poned in newly diagnosed patients. A multidisciplinary decision was required before the initiation of hydroxychloroquine based on the COVID-19 treatment protocol.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold>COVID-19 has caused challenges and transformed access to health care. However, these limitations have provided opportunities for the health care system to adapt. Further, telemedicine has become a reliable platform for follow-up appointments that should be conducted by a multidisciplinary team including physicians, dieticians, and physical therapists.<\/jats:p>","DOI":"10.3389\/fped.2021.629549","type":"journal-article","created":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T11:28:36Z","timestamp":1613734116000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Consensus Statement on the Management of Duchenne Muscular Dystrophy in Saudi Arabia During the Coronavirus Disease 2019 Pandemic"],"prefix":"10.3389","volume":"9","author":[{"given":"Ahmed K.","family":"Bamaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fouad","family":"Alghamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahla","family":"Alshaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed","family":"Altwaijri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad A.","family":"Bashiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Hundallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Musaad","family":"Abukhaled","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama Y.","family":"Muthaffar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Al-Mehmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahani Ahmed","family":"Jamaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad A.","family":"Al-Muhaizea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulaziz","family":"Al-Saman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,2,17]]},"reference":[{"key":"B1","unstructured":"Identifying the Source of the Outbreak.2020"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.3201\/eid2607.200885","article-title":"Aerosol and surface distribution of severe acute respiratory syndrome coronavirus 2 in hospital wards, Wuhan, China, 2020","volume":"26","author":"Guo","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s42399-020-00363-4","article-title":"Comorbidity and its impact on patients with COVID-19","volume":"2","author":"Sanyaolu","year":"2020","journal-title":"SN Compr Clin Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.36185\/2532-1900-008","article-title":"Estimating the impact of COVID-19 pandemic on services provided by Italian neuromuscular centers: an Italian Association of Myology survey of the acute phase","volume":"39","author":"Mauri","year":"2020","journal-title":"Acta Myol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"104917","DOI":"10.1016\/j.phrs.2020.104917","article-title":"Safety issues and harmful pharmacological interactions of nutritional supplements in Duchenne muscular dystrophy: considerations for Standard of Care and emerging virus outbreaks","volume":"158","author":"Boccanegra","year":"2020","journal-title":"Pharmacol Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3233\/PRM-200748","article-title":"Pediatric telerehabilitation medicine: making your virtual visits efficient, effective and fun","volume":"13","author":"Rabatin","year":"2020","journal-title":"J Pediatr Rehabil Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41586-020-2405-7","article-title":"Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe","volume":"584","author":"Flaxman","year":"2020","journal-title":"Nature"},{"key":"B8","unstructured":"People With Certain Medical Conditions.2020"},{"key":"B9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management","volume":"9","author":"Bushby","year":"2010","journal-title":"Lancet Neurol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","article-title":"Dystrophin: the protein product of the duchenne muscular dystrophy locus","volume":"51","author":"Hoffman","year":"1987","journal-title":"Cell"},{"key":"B11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/mus.880010204","article-title":"Becker-type muscular dystrophy","volume":"1","author":"Bradley","year":"1978","journal-title":"Muscle Nerve"},{"key":"B12","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S1474-4422(18)30024-3","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/mt.2011.59","article-title":"Current status of pharmaceutical and genetic therapeutic approaches to treat DMD","volume":"19","author":"Pichavant","year":"2011","journal-title":"Mol Ther"},{"key":"B14","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jmoldx.2010.11.018","article-title":"Quality assurance for duchenne and becker muscular dystrophy genetic testing","volume":"13","author":"Kalman","year":"2011","journal-title":"J Mol Diagn"},{"key":"B15","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/jcph.842","article-title":"A novel NF-\u03baB inhibitor, edasalonexent (CAT-1004), in development as a disease-modifying treatment for patients with Duchenne muscular dystrophy: phase 1 safety, pharmacokinetics, and pharmacodynamics in adult subjects","volume":"57","author":"Donovan","year":"2017","journal-title":"J Clin Pharmacol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.phrs.2018.09.007","article-title":"Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug","volume":"136","author":"Conklin","year":"2018","journal-title":"Pharmacol Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1111\/apa.15270","article-title":"Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults","volume":"109","author":"Ludvigsson","year":"2020","journal-title":"Acta Paediatr"},{"key":"B18","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.jiph.2020.05.026","article-title":"Clinical characteristics of COVID-19 in Saudi Arabia: a national retrospective study","volume":"13","author":"Alsofayan","year":"2020","journal-title":"J Infect Public Health"},{"key":"B19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/mus.26902","article-title":"The care of patients with Duchenne, Becker, and other muscular dystrophies in the COVID\u221219 pandemic","volume":"62","author":"Veerapandiyan","year":"2020","journal-title":"Muscle Nerve"},{"key":"B20","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S1474-4422(18)30025-5","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol"},{"key":"B21","unstructured":"A Consensus Statement from the Cardiac Services Development Team at the Ministry of Health of Saudi Arabia.2020"},{"key":"B22","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.cardfail.2020.04.013","article-title":"Joint HFSA\/ACC\/AHA statement addresses concerns re: using RAAS antagonists in COVID-19","volume":"26","author":"Bozkurt","year":"2020","journal-title":"J Card Fail"},{"key":"B23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.5195\/IJT.2018.6253","article-title":"Case studies in physical therapy: transitioning a \u201cHands-On\u201d approach into a virtual platform","volume":"10","author":"Turner","year":"2018","journal-title":"Int J Telerehabil"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1007\/s40618-020-01266-w","article-title":"COVID-19 infection and glucocorticoids: update from the Italian Society of Endocrinology Expert Opinion on steroid replacement in adrenal insufficiency","volume":"43","author":"Isidori","year":"2020","journal-title":"J Endocrinol Invest"},{"key":"B25","unstructured":"PJ Nicholoff Steroid Protocol2018"},{"key":"B26","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.1212\/WNL.94.15_supplement.4461","article-title":"Duchenne muscular dystrophy (DMD) and vitamin D deficiency (4461)","volume":"94","author":"Tribble","year":"2020","journal-title":"Neurology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2333794X19835661","DOI":"10.1177\/2333794X19835661","article-title":"Increased rates of vitamin D insufficiency in boys with duchenne muscular dystrophy despite higher vitamin D3 supplementation","volume":"6","author":"Bian","year":"2019","journal-title":"Glob Pediatr Health"},{"key":"B28","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12948-020-00139-0","article-title":"Vitamin D and Covid-19: an update on evidence and potential therapeutic implications","volume":"18","author":"Murdaca","year":"2020","journal-title":"Clin Mol Allergy"},{"key":"B29","doi-asserted-by":"publisher","first-page":"156","DOI":"10.5582\/bst.2020.03072","article-title":"Update on use of chloroquine\/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19)","volume":"14","author":"Gao","year":"2020","journal-title":"Biosci Trends"},{"key":"B30","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/ajh.20294","article-title":"Hydroxychloroquine causes severe vacuolar myopathy in a patient with chronic graft-versus-host disease","volume":"78","author":"Bola\u00f1os-Meade","year":"2005","journal-title":"Am J Hematol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1111\/neup.12520","article-title":"Hydroxychloroquine-induced autophagic vacuolar myopathy with mitochondrial abnormalities","volume":"38","author":"Khosa","year":"2018","journal-title":"Neuropathology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/phar.2387","article-title":"Chloroquine and hydroxychloroquine in the Era of SARS\u2014CoV2: caution on their cardiac toxicity","volume":"40","author":"Bauman","year":"2020","journal-title":"Pharmacotherapy"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.629549\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T13:26:06Z","timestamp":1724505966000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.629549\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,17]]},"references-count":32,"alternative-id":["10.3389\/fped.2021.629549"],"URL":"https:\/\/doi.org\/10.3389\/fped.2021.629549","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,17]]},"article-number":"629549"}}